sera from 119 patients with nasopharyngeal carcinoma ( npc ) , 33 patients with other cancers of the head and neck , 220 normal subjects and various numbers of patients with each of the other nine most common cancers in taiwan were examined for their serum antibody response to epstein-barr virus ( ebv ) -specific dnase .
C2931822
nasopharyngeal carcinoma
C0027530
neck